AnaptysBio's Series D Round

AnaptysBio raised a round of funding on July 15, 2015.

AnaptysBio is a privately-held company focused on the generation of antibody therapeutics and is the leader in the use of somatic hypermutation (SHM) for antibody discovery and optimization. The compa…

Articles about AnaptysBio's Series D Round: